Synjardy is a prescription medication that combines empagliflozin (12.5mg) and metformin hydrochloride (1000mg) in film-coated tablets. Manufactured by Boehringer Ingelheim, this combination therapy comes in a pack of 60 tablets and is used to treat type 2 diabetes mellitus. This medication contains two active ingredients that work together to help control blood sugar levels in adults with type 2 diabetes: empagliflozin (a sodium-glucose co-transporter 2 inhibitor) and metformin hydrochloride (a biguanide). The tablets are film-coated for oral administration and should be taken as prescribed by a healthcare provider, typically twice daily with meals. This is a prescription-only medication that requires regular medical monitoring.